Close

Alcobra Ltd. (ADHD) Reports Update on MDX Phase 3 in Adults with ADHD

October 23, 2014 7:29 AM EDT Send to a Friend
Alcobra Ltd. (Nasdaq: ADHD) announced the presentation of new data from a Phase III study of Metadoxine Extended Release (MDX) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login